Clinical and Pre-Clinical Predictors of Response to Gattex in Short Bowel Syndrome

About this Study

Gattex is one FDA approved medication to treat short bowel syndrome. Gattex is known to promote mucosal growth and increase enterocyte mass. In this observational study, we will examine the innate lymphoid cells (ILCs) in blood and intestinal biopsies of subjects treated with Gattex. The study will collect historical medical records and biological samples.

Sponsor Protocol ID:2019-0325
IRB Number:2019-0325
Actively Enrolling
Interventional
Early Phase 1
February 11, 2020
Eligibility Criteria
18 years old
Both Male and Female
No
No
Yes

Inclusion Criteria

Inclusion criteria for Group 1 cohort:                

  1. Male or female subject 18 years of age and older with a confirmed diagnosis of short bowel syndrome due to Crohn’s Disease.
  2. Currently on Gattex.

 

Inclusion criteria for Group 2 cohort

1.    Male and female subject 18 years of age and older with a confirmed diagnosis of short bowel syndrome due to Crohn’s Disease.

2.    Currently not on Gattex

Inclusion criteria for Group 3 cohort

1.    Male or female subject 18 years of age and older with a confirmed diagnosis of short bowel syndrome due to vascular compromise

2.    Currently on Gattex.

Inclusion criteria for Group 4 cohort

1.    Male or female subject 18 years of age and older with a confirmed diagnosis of short bowel syndrome due to vascular compromise.

2.    Currently not on Gattex.

Exclusion Criteria

Exclusion criteria for all cohorts:        

1.    Pregnant women

2.    Diabetes mellitus requiring insulin; or

3.    Solid organ or stem cell transplant recipient; or

4.    Other medical condition requiring immune suppression


Categories Click category to view its trials.
Digestive Conditions
Participating Locations
Belhaven Building - UMMC
University Hospital - UMMC
Contact Information
Contact Name: Yilanys Pride
Phone Number: 601-496-2009
Email: ypride@umc.edu
Principal Investigator:Stephanie Glover
How to participate in our Clinical Trials